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OBJECTIVE—The number of people with metabolic syndrome is increasing worldwide, and
changes in socioenvironmental factors contribute to this increase. Therefore, investigation of
changes in metabolic syndrome and its components in South Korea, where rapid socioenviron-
mental changes have occurred in recent years, would be foundational in setting up an effective
strategy for reducing this increasing trend.
RESEARCH DESIGN AND METHODS—We compared the prevalence and pattern of
metabolic syndrome among participants inthe Korean National Health and Nutrition Examination
Surveysfor1998,2001,2005,and2007.Ineachsurvey,stratiﬁed,multistage,probability–sampling
designs and weighting adjustments were conducted to represent the entire Korean population.
The revised National Cholesterol Education Program criteria were used as the deﬁnition of
metabolic syndrome. All biochemical parameters were measured in a central laboratory.
RESULTS—A total of 6,907 (mean 6 SE age 45.0 6 0.2 years), 4,536 (45.5 6 0.2), 5,373
(47.160.2),and2,890(49.960.3)Koreansover20yearsofagehaveparticipatedinthestudies
in 1998, 2001, 2005, and 2007, respectively. The age-adjusted prevalence of metabolic syn-
drome increased signiﬁcantlyfrom 24.9% in 1998, 29.2%in2001,and 30.4% in 2005to 31.3%
in 2007. Among the ﬁve components, the level of low HDL cholesterol increased the most, by
13.8% over the 10 years. Abdominal obesity and hypertriglyceridemia followed, with 8.7 and
4.9% increases, respectively.
CONCLUSIONS—Because dyslipidemia and abdominal obesity were majorfactors in increasing
the prevalence of metabolic syndrome in Koreans for the past 10 years, lifestyle interventions should
be conducted at the national level to reduce the burden and consequences of metabolic syndrome.
Diabetes Care 34:1323–1328, 2011
M
etabolic syndrome increases car-
diovascular morbidity and mor-
tality and all-cause mortality (1).
M e t a b o l i cs y n d r o m ea l s oi n c r e a s e st h e
risk of developing diabetes because its
components represent major risk factors
for impaired glucose metabolism (2).
The prevalence of metabolic syn-
drome is increasing worldwide. Accord-
ing to data from the National Health
and Nutrition Examination Survey
(NHANES) III and NHANESs 1999–
2006, the age-adjusted prevalence of met-
abolic syndrome increased from 29.2 to
34.2% in the U.S. (3). This increasing
trend also has been observed in Asian
countries (4), presenting a major chal-
lenge for public health professionals as
well as becoming a social and economic
problem in the near future.
The characteristics of metabolic syn-
drome can differ according to ethnicity
andsocioeconomicdifferencesandchanges.
As a consequence, Asians have a higher
prevalence of metabolic syndrome than
whites after adjusting for body size (5).
Hence, understanding the socioeconomic
context of Asian populations is critical in
establishing appropriate strategies for
addressing this wide prevalence. South
Korea is distinct for experiencing a major
economic crisis in 1998, followed by a
rapid recovery through adopting Western
policies and cultures. This sudden change
of the socioenvironment resulted in a dra-
matic lifestyle change for people living in
South Korea. Today, South Koreans are
eating more “Western” food and are less
physically active than a decade ago. South
Korea is one of the countries where the
socioeconomic environment has changed
rapidly to reﬂect more Westernization as
well as its negative health consequences.
Thus, documenting the changes in meta-
bolic syndrome characteristics in South
Korea during this period of socioeco-
nomic changes is intriguing and impor-
tant. In this study, we investigated the
changes in the prevalence of metabolic
syndrome in four nationwide surveys
(the Korean NHANESs [KNHANESs] in
1998, 2001, 2005, and 2007) by applying
the revised National Cholesterol Educa-
tion Program (NCEP) deﬁnition (6). We
alsoinvestigated thechangesinthefactors
constituting metabolic syndrome.
RESEARCH DESIGN AND
METHODS
Study cohort
The Korean Ministry of Health and Wel-
fare conducted the KNHANES in non-
institutionalized Korean civilians in the
years 1998, 2001, 2005, and 2007. De-
tails of the surveys performed in 1998,
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Epidemiology/Health Services Research
ORIGINAL ARTICLE2001, and 2005 have been described
(7,8). A similar design and method were
used in the KNHANES for 2007. In
brief, a stratiﬁed, multistage, probability–
sampling design was used, with the selec-
tion made from sampling units based on
geographical area, sex, and age-groups
using household registries. Trained inves-
tigators conducted surveys in households
a n da d m i n i s t e r e dq u e s t i o n n a i r e st oa d u l t s .
Household surveys included the demo-
graphic, socioeconomic, dietary, and med-
ical history of each respondent. Of 11,318
people who participated in the 1998 sur-
vey, complete data were obtained from
9,795 (86.5%). Similarly, 9,808 (83.9%)
of11,694subjectsin2001,7,597(70.2%)
of 10,816 subjects in 2005, and 4,246
(65.8%) of 6,455 subjects in 2007 par-
ticipated in each survey. To show that
therewasnobiasasaresultofdropouts,
we compared important demographic
and other characteristics of the non-
completers with those of the complet-
ers. There was no signiﬁcant difference
between participants and nonpartici-
pants in all studies. Among these sub-
jects, 6,907 respondents in 1998, who
were aged .20 years and had all the
data for deﬁning metabolic syndrome
with the revised NCEP deﬁnition, were
available for analysis. Likewise, for the
2001, 2005, and 2007 surveys, 4,536,
5,373, and 2,890 participants, respec-
tively, aged $20 years had complete
data.
To give an equal probability of being
sampled, weights were assigned to each
respondent, enabling the results to repre-
sent the entire Korean population. This
weighting method guarantees unbiased
point estimates of population parameters
for the entire population and its subsets
(9).Allsubjectsinthestudiesparticipated
voluntarily, and informed consent was
obtained from them. The study protocol
was approved by the Ministry of Health
and Welfare in Korea.
Anthropometry
Anthropometricmeasurementswerecon-
ducted by well-trained examiners in the
same manner in the four studies. Height
was measured to the nearest 0.1 cm
using a portable stadiometer (Seriter,
Bismarck, ND). Weight was measured to
the nearest 0.1 kg using a calibrated
balance-beam scale (Giant-150N; Hana,
Seoul, Korea). Waist circumference mea-
surements weretakenattheendofnormal
expiration to the nearest 0.1 cm, measur-
ing from the narrowest point between the
lower borders of the rib cage and the iliac
crest.
Measurement of metabolic risk
factors
For each study, subjects were asked to
refrain from smoking or consuming caf-
feine before the measurement. Blood pres-
sure was measured twice, using a mercury
sphygmomanometer (Baumanometer;
Baum, Copiague, NY), in the sitting posi-
tion after at least a 10-min rest. If the ﬁrst
two measurements differed by .5 mmHg,
additional checks were obtained.
After a 12-h overnight fast, venous
blood samples were drawn.Sampleswere
immediately sent to a central, certiﬁed
laboratory, and plasma was separated
immediately by centrifugation. The fast-
ing plasma concentrations of glucose and
lipids were measured enzymatically in a
central laboratory; a 747-chemistry ana-
lyzer (Hitachi, Tokyo, Japan) was used in
the 1998 and 2001 studies, and an Advia
1650/2400(Siemens, NewYork,NY)was
used in the 2005 and 2007 studies.
To conﬁrm and compare accuracy
and consistency in each survey, commut-
able frozen serum samples (n = 38) were
taken from normal subjects and patients
with dyslipidemia, according to the Clin-
ical and Laboratory Standards Institute
guidelines (www.clsi.org/). The commut-
able frozen serum samples were sent to
the Centers for Disease Control and Pre-
vention (Atlanta, GA) and were measured
using the standard method. With data
from the Centers for Disease Control
and Prevention, the conversion rate for
the KNHANES 2007 was obtained by a
Passing and Bablok regression method
(Supplementary Fig. A). The revised
HDL cholesterol extrapolations were
basedonaregressionline,anditmaythe-
oretically cause excess residual error for
prediction.However,the ﬁttedregression
line had an R
2 = 0.977. Therefore, the re-
vised HDL cholesterol values were statis-
tically well substantiated. Conversion
rates for other surveys were obtained
by a similar method as follows:
c Revised HDL cholesterol = 0.989 3
HDL cholesterol (KNHANES 2007) +
6.162
c Revised HDL cholesterol = 1.160 3
HDL cholesterol (KNHANES 2005) –
1.800
c Revised HDL cholesterol = 0.712 3
HDL cholesterol (KNHANES 2001 or
1998) + 12.470
Deﬁnition of metabolic syndrome
According to the revised NCEP criteria
(6), an individual may be diagnosed as
having metabolic syndrome if he or she
hasthreeormoreofthefollowingcriteria:
1) waist circumference .90 cm in men
and .80 cm in women using the Interna-
tional Obesity Task Force criteria for the
Asian-Paciﬁc population to determine
waist circumference (10); 2) triglycerides
$150 mg/dL or medication use; 3)H D L
cholesterol ,40 mg/dL in men and ,50
mg/dL in women or medication use; 4)
blood pressure $130/85 mmHg or anti-
hypertensive medication use; and 5)f a s t -
ing glucose $100 mg/dL or medication
use (insulin or oral agents).
Statistical analysis
Alldataarepresentedasmeans6SEoras
prevalence (% and SE). Sampling weights
were used to take the complex sampling
into account, and statistical analyses were
conductedusingSASversion8.1software
with survey procedure (SAS Institute,
Inc., Cary, NC). Direct age adjustment
of the data was done for the Korean pop-
ulation aged $20 years in the year 2007.
Everycomparison among thefourstudies
was done after age adjustment. Multiple
regression analysis, including survey year
and age as categorical variables, was per-
formed to compare the continuous vari-
ables associated with the cardiovascular
risk factors in each survey. x
2 Tests and
linear-by-linear association were used to
compare the prevalence of metabolic syn-
drome and its components, according to
the survey year and/or sex. Statistical sig-
niﬁcance was deﬁned as P , 0.05.
RESULTS—A total of 6,907 (mean 6
SE age 45.0 6 0.2 years), 4,536 (45.5 6
0.2), 5,373 (47.1 6 0.22), and 2,890
(49.9 6 0.3) Korean men and women
aged .20 years participated in the
KNHANES in 1998, 2001, 2005, and
2007, respectively. The age-adjusted
prevalence of metabolic syndrome in-
creased signiﬁcantly from 24.9% in
1998 to 31.3% in 2007. The total 6.4%
increase of prevalence of metabolic syn-
drome overthe10-yearperiodisestimated
to be ~0.6% of the annual metabolic
syndrome increase. If the original NCEP
criteria for abdominal obesity of 102 cm
in men and 88 cm in women were used,
15.4 and 20.6% of the Korean popula-
tion would be classiﬁed as having meta-
bolic syndrome in the 1998 and 2007
surveys, respectively (5.2% increase over
10 years).
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Metabolic syndrome in KoreaTable 1 shows the mean anthropo-
metric and biochemical parameters in
the 1998, 2001, 2005, and 2007 surveys.
Participants in the 2007 survey were ~4.9
years older than those in the 1998 survey.
Obesity indices, such as BMI and waist
circumference, and lipid proﬁles, such
as triglycerides and LDL cholesterol, in-
creased signiﬁcantly over 10 years (P ,
0.05). In contrast, systolic and diastolic
blood pressure decreased signiﬁcantly
over the same period (P , 0.05).
Table 2 shows the prevalence of met-
abolic syndrome and its individual com-
ponents among the U.S. NHANESs and
the four KNHANESs. The prevalence of
abdominal obesity, hypertriglyceridemia,
and glucose criteria increased signiﬁ-
cantly in both countries. Compared with
the U.S. NHANESs, the prevalence of high
blood pressure has been decreasing in
Korea. The prevalence of low HDL choles-
terolemia decreased in the U.S. NHANES
reports, but the opposite trend was
observed in Korea. Of ﬁve individual met-
abolic syndrome components, the inci-
dence of low HDL cholesterol criteria
increased the most over 10 years (13.8%).
Abdominal obesity and hypertriglycer-
idemia followed, showing 8.7 and 4.9%
increases,respectively.Incontrast,subjects
meeting the blood pressure criteria de-
creased gradually. Even after stratifying
subjects by antihypertensive medication
status, a decreasing trend in blood pres-
sured remained (Supplementary Fig. B).
There was a 5.5% difference in met-
abolicsyndromeprevalencebetweenmen
and women (22.4% in men and 27.9% in
women)in1998.Inthe2007KNHANES,
there was a 3.9% difference between men
and women; women had a signiﬁcantly
higher prevalence (32.9%) than men
(29.0%; P , 0.05). However, the overall
increase in metabolic syndrome preva-
lence over the 10 years was signiﬁcantly
h i g h e ri nm e n( 6 . 6 % )t h a ni nw o m e n
(5.0%; P , 0.05).
The prevalence of metabolic syn-
drome among Korean adults by sex in
the four KNHANESs is shown according
to age-groups (Fig. 1). In all studies, the
prevalenceofmetabolicsyndromeinmen
was higher than in women aged 20–49
years, but the prevalence of metabolic
syndrome in women increased signiﬁ-
cantly at age 50 years and surpassed men
thereafter.
In comparing the components of
metabolic syndrome using the revised
NCEP criteria (Fig. 2), men had a higher
prevalence of fasting glucose, abnormal
blood pressure, and hypertriglyceridemia
criteria than women (all P , 0.05). In
contrast, women showed a higher preva-
lence of abdominal obesity and low HDL
cholesterolemia(bothP,0.05).Theage-
speciﬁc prevalence rates of the metabolic
syndrome component using the revised
NCEP deﬁnition for 1998, 2001, 2005,
a n d2 0 0 7a r es h o w ni nS u p p l e m e n t a r y
Fig. C. It is noteworthy that, in all four
studies, there was a tendency for men to
have a relatively higher prevalence of in-
creased fasting glucose, blood pressure,
and hypertriglyceridemia at younger
ages (20–49 years) than women.
CONCLUSIONS—When the revised
NCEP deﬁnition using the Asia-Paciﬁc
abdominal obesity criteria was applied,
the age-adjusted prevalence of metabolic
syndrome was 24.9% in the KNHANES
1998 and 31.3% in the KNHANES 2007.
The estimated annualincrease was ~0.6%
over 10 years. Low HDL cholesterol, ab-
dominal obesity, and hypertriglyceridemia
played major roles in this increase.
The prevalence of metabolic syn-
drome in the KNHANES 2007 was
31.3%, which was similar to the result
of the U.S. NHANESs for 1999–2006 at
34.2%,using therevisedNCEPdeﬁnition
(3). However, it should be noted that
lower criteria of abdominal obesity were
used in the four KNHANESs than in the
U.S. NHANESs. Indeed, the best BMI for
Americansis25kg/m
2forlifeexpectancy,
whereas the best BMI for Koreans is 23
kg/m
2, based on hundreds of thousands
of people for the extended .20-year lon-
gitudinal follow-up (11,12). Our distinc-
tive data reserve plenty of reasons to use
the standard criteria for metabolic syn-
drome in Koreans.
When comparing the percentage
changes in the ﬁve components of meta-
bolic syndrome, the prevalence of low
HDLcholesterolincreasedthemost(from
36.4 to 50.2%, a 13.8% increase). Thus,
almost one-half of the Korean population
has a low HDL cholesterol level. Besides
HDL cholesterol, abdominal obesity and
hypertriglyceridemia also have increased
substantially.Bothlipidlevelsandobesity
are affected by lifestyle factors (13).
Changing to a high-fat diet and low phys-
ical activity in Korean seems to have con-
tributed to this high prevalence of
abdominal obesity and dyslipidemia
(14). In fact, Koreans’ total energy intake
increased from 1,985 and 1,976 kcal in
1998 and 2001, respectively, to 2,016
kcal in 2005 (15). Total fat intake also
Table 1—Age-adjusted anthropometric and biochemical parameters in the 1998, 2001,
2005, and 2007 KNHANESs
1998 2001 2005 2007
n 6,907 4,536 5,373 2,890
Age (years) 45.0 6 0.19 45.5 6 0.23 47.1 6 0.21 49.9 6 0.30
Women (%) 55.5 57.7 57.4 58.3
Weight (kg)* 60.7 6 0.13 61.6 6 0.16 62.2 6 0.15 61.5 6 0.21
Height (cm)* 161.5 6 0.11 161.7 6 0.14 161.7 6 0.12 160.9 6 0.17
BMI (kg/m
2)* 23.2 6 0.04 23.5 6 0.05 23.7 6 0.04 23.7 6 0.06
Waist circumference (cm)* 80.4 6 0.11 80.9 6 0.14 81.0 6 0.13 82.4 6 0.18
Systolic blood pressure
(mmHg)* 125.8 6 0.24 122.4 6 0.29 119.2 6 0.24 117.7 6 0.32
Diastolic blood pressure
(mmHg)* 78.5 6 0.14 76.9 6 0.17 77.3 6 0.15 75.7 6 0.19
Hemoglobin (g/dL)* 14.0 6 0.02 13.6 6 0.02 13.8 6 0.02 13.8 6 0.03
Hematocrit (%)* 41.5 6 0.06 40.7 6 0.06 42.1 6 0.06 40.9 6 0.09
AST (IU/L)* 28.1 6 0.21 22.4 6 0.12 24.4 6 0.18 25.1 6 0.27
ALT (IU/L)* 28.2 6 0.28 20.3 6 0.18 22.4 6 0.26 24.4 6 0.37
Creatinine (mg/dL)* 0.9 6 0.01 1.0 6 0.01 1.0 6 0.01 1.0 6 0.01
Total cholesterol (mg/dL)* 188.6 6 0.45 188.2 6 0.51 185.0 6 0.48 188.8 6 0.68
Triglycerides (mg/dL)* 122.5 6 0.74 130.4 6 1.16 135.6 6 1.66 131.7 6 1.45
HDL cholesterol (mg/dL)* 47.9 6 0.11 45.3 6 0.16 45.1 6 0.15 47.8 6 0.19
LDL cholesterol (mg/dL)* 114.1 6 0.41 114.5 6 0.46 112.8 6 0.42 117.4 6 0.60
Fasting plasma glucose
(mg/dL)* 99.5 6 0.36 97.6 6 0.25 95.2 6 0.31 96.2 6 0.42
Data are means 6 SE, unless otherwise indicated. AST, aspartate aminotransferase; ALT, alanine amino-
transferase. *Age-adjusted value.
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Lim and Associatesincreased from 41.5 and 41.6 g in 1998
and 2001, respectively, to 46.0 g in 2005
(15). The percentage of subjects walking
.30 min daily on .2 days a week de-
creased from 75.5% in 2001 to 60.7% in
2005(16).Inaddition,television-viewing
hours per week increased remarkably
from 18.4 h per week in 1993 to 23.7 h
per week in 2000, further contributing to
the sedentary lifestyle (17). Such lifestyle
changes are not unique to Korea, and
other developed or developing countries
report similar results (4,18).
Recently, several reports were pub-
lished from the KNHANES with alterna-
tive analyses (19–21). Kim et al. (19)
found that nutritional intakes were un-
equal by educational level and contrib-
uted this inequality to the economic
crisis in Korea in 1998. This inequality
of nutritional intake may be associated
with a rapid increase of low HDL choles-
terolemia. The other group reported that
the treatment rate for hypertension was
59–90% (20). This high treatment rate
may be associated with a decreasing ten-
dency of hypertension over the period.
Another study (21) provided increasing
trends in obesity measures among men
and older-aged women but not in young
women. This result is in accordance with
the current analysis.
When comparing the prevalence of
metabolic syndrome between men and
women stratiﬁed by age-groups, men
had a higher prevalence than women for
ages ,50 years in every study (Fig. 1). In
contrast, the prevalence of metabolic syn-
drome in women increased signiﬁcantly
from the age of 50 years and surpassed
men thereafter. Considering that this re-
markable increase in metabolic syndrome
was observed for women starting at the
ageof~50years,itseemslikelythatmeno-
pause could be a reason for this dramatic
change.Asimilarincreasingpatternofab-
dominal obesity in women supports this
hypothesis.
As shown in Table 1, obesity indices
andmetabolicimpairmentshavebeenris-
ing over the past 10 years. In contrast,
blood pressures have been signiﬁcantly
decreasing overthesameperiod. Interest-
ingly, these Korean data show conﬂicting
trends of HDL cholesterolemia and blood
pressure when compared with the U.S.
data. The prevalence of low HDL choles-
terolemia increased, whereas the preva-
lence of high blood pressure decreased
in Korea, and the inverse is true for the
U.S. NHANES III to NHANESs 1999–
2006(3).Thus,thecharacteristicsofmet-
abolic syndrome may change differently
accordingtoethnicityandsocioeconomic
status.
In this analysis, blood pressure de-
creased, whereas antihypertensive medi-
cation rate increased from 6.1% in 1998
to 18.5% in 2007. There is no clear ex-
planation to the decreasing pattern of
prevalence of blood pressure criteria over
the past 10 years in Korea. Several possi-
bilities can be suggested. Koreans were
traditionally used to eating a high-salt
diet; however, for the recent 10 years,
daily salt consumption decreased signiﬁ-
cantly as a result of the national campaign
encouraging the “Dietary Approach to
Stop Hypertension Diet” (22). Thus,
changes in the dietary pattern to a low-
salt diet could beone reasonfordecreasing
Table 2—Prevalence (% or SE) of metabolic syndrome and its individual metabolic abnormalities among the U.S. NHANES III,
1999–2006, and KNHANES 1998, 2001, 2005, and 2007
U.S. NHANES KNHANES
P* III 1999–2006 1998 2001 2005 2007
n 6,423 6,962 6,907 4,536 5,373 2,890
Metabolic syndrome
Unadjusted 27.9 (1.1) 34.1 (0.8) 24.4 (0.6) 28.1 (0.7) 29.2 (0.6) 31.3 (0.6) ,0.01
Age-adjusted 29.2 (1.0) 34.2 (0.7) 24.9 (0.6) 29.2 (0.7) 30.4 (0.6) 31.3 (0.6) ,0.01
Men 31.4 (1.4) 34.9 (1.0) 22.4 (1.3) 26.9 (1.2) 31.7 (1.5) 29.0 (1.6) ,0.01
Women 27.1 (1.2) 33.3 (1.0) 27.9 (1.2) 31.8 (1.4) 29.5 (1.5) 32.9 (1.8) ,0.01
Abdominal obesity†
U.S. adult criteria 38.6 (1.0) 49.6 (0.8) ——— — —
Men (.102 cm) 30.4 (1.6) 41.1 (1.1) ——— — —
Women (.88 cm) 46.0 (1.4) 58.0 (1.1) ——— — —
Asian criteria —— 32.5 (0.5) 34.5 (0.6) 35.3 (0.5) 41.3 (0.9) ,0.01
Men (.90 cm) —— 20.4 (1.2) 22.4 (1.1) 26.6 (1.3) 27.5 (1.6) —
Women (.80 cm) —— 42.2 (1.3) 43.4 (1.5) 41.7 (1.2) 51.2 (2.1) —
Triglycerides ($150 mg/dL or medication use) 30.3 (1.2) 32.0 (0.7) 28.3 (0.5) 33.2 (0.6) 29.9 (0.9) 33.2 (1.1) ,0.01
Men 36.0 (1.9) 36.1 (1.1) 36.1 (1.4) 43.0 (1.5) 39.7 (1.8) 40.8 (1.8) —
Women 24.7 (1.2) 27.6 (0.8) 22.1 (1.6) 26.0 (1.7) 22.6 (1.9) 27.8 (2.0) —
HDL cholesterol 38.0 (1.3) 30.7 (0.8) 36.4 (0.5) 48.4 (0.7) 51.9 (0.5) 50.2 (1.2) ,0.01
Men (,40 mg/dL or medication use) 36.4 (1.7) 27.6 (1.0) 25.5 (1.5) 32.6 (1.9) 35.2 (1.9) 34.7 (1.9) —
Women (,50 mg/dL or medication use) 39.6 (1.4) 33.8 (1.1) 47.9 (1.7) 60.1 (1.8) 61.2 (1.7) 59.3 (2.3) —
Blood pressure ($130/85 mmHg or medication use) 32.0 (0.8) 40.0 (0.7) 41.0 (0.6) 37.0 (0.6) 37.5 (0.8) 34.5 (0.7) ,0.01
Men 36.2 (1.5) 42.9 (0.7) 48.0 (1.3) 44.3 (2.1) 46.6 (1.2) 40.6 (1.6) —
Women 27.8 (0.9) 36.6 (0.8) 35.3 (1.6) 31.7 (1.9) 30.7 (1.4) 30.1 (1.5) —
Fasting glucose ($100 mg/dL or medication use) 32.5 (1.1) 36.9 (1.0) 23.9 (0.6) 25.5 (0.7) 23.3 (0.5) 26.3 (0.9) ,0.01
Men 41.5 (1.5) 44.7 (1.2) 25.1 (1.3) 26.7 (1.8) 29.3 (1.3) 31.8 (2.1) —
Women 24.2 (1.2) 29.2 (1.0) 22.9 (1.5) 24.5 (1.6) 18.8 (1.9) 22.3 (2.5) —
Data are percentage (SE). *Revised NCEP Adult Treatment Panel III and Asia-Paciﬁc criteria for abdominal obesity were used for the U.S. NHANES and KNHANES,
respectively. †Linear-by-linear association was used for signiﬁcance of trend from the 1998 to 2007 KNHANES.
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Metabolic syndrome in Koreablood pressure, which was proven in
Japan (23). A decrease in the smoking rate
in men from 69.9% in 2001 to 42.0% in
2007 is believed to contribute to the
decreasing pattern of high blood pressure
(24). A dramatic increase in cardiovascu-
lar mortality in 1999, when South Korea
experienced an economic crisis, could be
another possible explanation for the de-
creasing trend in high blood pressure
(25). The high cardiovascular mortality
in 1999 leveled off and returned to an av-
erage level in the following years. In addi-
tion, there may be a possibility that the
measurement of blood pressure had be-
come more stabilized over time.
South Korea is a good example dem-
onstrating the impact of rapid lifestyle
changes over a relatively short period on
prevalence of metabolic abnormalities.
South Korea experienced a major eco-
nomic crisis in 1998, followed by a rapid
and impressive economic recovery that is
compatible to other developed countries.
Thus, documenting such changes in met-
abolic syndrome characteristics in South
Korea during this economic boom is crit-
ical in understanding the socioeconomic
inﬂuence on public health.
In conclusion, the prevalence of met-
abolic syndrome increased rapidly from
the KNHANES 1998 to the KNHANES
2007.Judgingfromthisdramaticincrease
during these 10 years, a national strategy
to prevent this increasing trend of meta-
bolicsyndromeshouldbedeveloped.The
ﬁrst priority should be to reduce the
burden of dyslipidemia and abdominal
obesity. Lifestyle changes, such as regular
exercise and a healthy diet with low
sodium, carbohydrates, and fat, should
be emphasized (6).
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